Companies / Vertex Pharmaceuticals Inc / Ma / Activity

Activity — Vertex Pharmaceuticals Inc / Ma

144 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
May 1, 2026Garber Alan M
Director
GrantCommon Stock$0+472
+6.87%
7,344
<0.01% of shares
low
Feb 17, 2026Bunnage Mark E.
Executive
GrantCommon Stock$0+3K
+24.31%
13,215
<0.01% of shares
low
Feb 17, 2026McKechnie Duncan
Executive
GrantCommon Stock$0+5K
+25.41%
24,490
<0.01% of shares
low
Jan 22, 2026McKechnie Duncan
Executive
GrantCommon Stock$0+2K
+9.97%
22,938
<0.01% of shares
low
Jan 22, 2026McKechnie Duncan
Executive
GrantCommon Stock$0+5K
+29.25%
20,858
<0.01% of shares
low
Feb 17, 2026Atkinson Edward Morrow III
Executive
GrantCommon Stock$0+5K
+24.63%
25,105
<0.01% of shares
low
Jan 22, 2026Atkinson Edward Morrow III
Executive
GrantCommon Stock$0+4K
+18.68%
24,669
<0.01% of shares
low
Jan 22, 2026Atkinson Edward Morrow III
Executive
GrantCommon Stock$0+4K
+23.34%
20,786
<0.01% of shares
low
Feb 17, 2026Ambrose Kristen
Executive
GrantCommon Stock$0+2K
+20.71%
10,543
<0.01% of shares
low
Jan 22, 2026Ambrose Kristen
Executive
GrantCommon Stock$0+1K
+12.04%
12,095
<0.01% of shares
low
Jan 22, 2026Ambrose Kristen
Executive
GrantCommon Stock$0+3K
+37.60%
10,795
<0.01% of shares
low
Feb 17, 2026Bozic Carmen
Executive
GrantCommon Stock$0+5K
+14.12%
43,428
0.02% of shares
low
Jan 22, 2026Bozic Carmen
Executive
GrantCommon Stock$0+3K
+8.55%
44,002
0.02% of shares
low
Jan 22, 2026Bozic Carmen
Executive
GrantCommon Stock$0+8K
+24.08%
40,535
0.02% of shares
low
Feb 17, 2026Tatsis Ourania
Executive
GrantCommon Stock$0+6K
+12.55%
51,921
0.02% of shares
low
Jan 22, 2026Tatsis Ourania
Executive
GrantCommon Stock$0+4K
+7.74%
54,042
0.02% of shares
low
Jan 22, 2026Tatsis Ourania
Executive
GrantCommon Stock$0+8K
+18.60%
50,159
0.02% of shares
low
Feb 17, 2026Biller Jonathan
Executive
GrantCommon Stock$0+4K
+24.56%
20,973
<0.01% of shares
low
Jan 22, 2026Biller Jonathan
Executive
GrantCommon Stock$0+3K
+12.84%
24,374
<0.01% of shares
low
Jan 22, 2026Biller Jonathan
Executive
GrantCommon Stock$0+6K
+41.12%
21,600
<0.01% of shares
low
Feb 17, 2026Kewalramani Reshma
CEO
GrantCommon Stock$0+16K
+12.23%
149,813
0.06% of shares
low
Jan 22, 2026Kewalramani Reshma
CEO
GrantCommon Stock$0+12K
+8.31%
154,825
0.06% of shares
low
Jan 22, 2026Kewalramani Reshma
CEO
GrantCommon Stock$0+27K
+23.26%
142,940
0.06% of shares
low
Jan 22, 2026Altshuler David
Executive
GrantCommon Stock$0+3K
+10.68%
34,477
0.01% of shares
low
Jan 22, 2026Altshuler David
Executive
GrantCommon Stock$0+8K
+33.78%
31,149
0.01% of shares
low
Feb 17, 2026Sachdev Amit
Executive
GrantCommon Stock$0+6K
+8.85%
71,182
0.03% of shares
low
Jan 22, 2026Sachdev Amit
Executive
GrantCommon Stock$0+4K
+5.79%
70,998
0.03% of shares
low
Jan 22, 2026Sachdev Amit
Executive
GrantCommon Stock$0+8K
+13.28%
67,115
0.03% of shares
low
Feb 17, 2026Leiden Jeffrey M
Executive
GrantCommon Stock$0+8K
+25.03%
41,308
0.02% of shares
low
Jan 22, 2026Leiden Jeffrey M
Executive
GrantCommon Stock$0+9K
+37.51%
33,039
0.01% of shares
low
Feb 17, 2026Wagner Charles F Jr
Executive
GrantCommon Stock$0+7K
+16.85%
51,080
0.02% of shares
low
Jan 22, 2026Wagner Charles F Jr
Executive
GrantCommon Stock$0+4K
+8.82%
51,325
0.02% of shares
low
Jan 22, 2026Wagner Charles F Jr
Executive
GrantCommon Stock$0+9K
+25.02%
47,165
0.02% of shares
low
Feb 27, 2026Kewalramani Reshma
CEO
SellCommon Stock$57.8K-120
-0.09%
137,758
0.05% of shares
low
Feb 25, 2026Ambrose Kristen
Executive
SellCommon Stock$108.5K-223
-3.10%
6,981
<0.01% of shares
medium
Feb 27, 2026Kewalramani Reshma
CEO
SellCommon Stock$115.9K-240
-0.17%
137,518
0.05% of shares
medium
Feb 25, 2026Tatsis Ourania
Executive
SellCommon Stock$126.5K-260
-0.55%
46,763
0.02% of shares
medium
Feb 13, 2026Bhatia Sangeeta N.
Director
SellCommon Stock$133.0K-266
-5.83%
4,299
<0.01% of shares
medium
Feb 26, 2026Ambrose Kristen
Executive
SellCommon Stock$172.6K-357
-5.11%
6,624
<0.01% of shares
medium
Feb 18, 2026Tatsis Ourania
Executive
SellCommon Stock$174.3K-368
-0.75%
48,650
0.02% of shares
medium
Feb 27, 2026Kewalramani Reshma
CEO
SellCommon Stock$191.9K-400
-0.29%
137,878
0.05% of shares
medium
Feb 11, 2026Tatsis Ourania
Executive
SellCommon Stock$214.6K-466
-0.90%
51,436
0.02% of shares
medium
Feb 27, 2026Kewalramani Reshma
CEO
SellCommon Stock$225.1K-460
-0.35%
131,270
0.05% of shares
medium
Feb 24, 2026Ambrose Kristen
Executive
OtherCommon Stock$264.9K-546
-7.05%
7,204
<0.01% of shares
low
Feb 10, 2026Ambrose Kristen
Executive
OtherCommon Stock$277.3K-592
-4.89%
11,503
<0.01% of shares
low
Feb 24, 2026Bunnage Mark E.
Executive
OtherCommon Stock$282.3K-582
-6.86%
7,904
<0.01% of shares
low
Feb 17, 2026Ambrose Kristen
Executive
OtherCommon Stock$289.3K-598
-5.67%
9,945
<0.01% of shares
low
Feb 17, 2026Tatsis Ourania
Executive
SellCommon Stock$298.1K-609
-1.23%
49,018
0.02% of shares
medium
Feb 25, 2026Bunnage Mark E.
Executive
SellCommon Stock$301.5K-620
-7.84%
7,284
<0.01% of shares
medium
Feb 18, 2026Ambrose Kristen
Executive
SellCommon Stock$302.2K-638
-7.61%
7,750
<0.01% of shares
medium
← PrevPage 1 of 3Next →